Company news
Cannara Biotech, Inc. news in 2026
Cannara Biotech, Inc.'s news releases, calls and decks from 2026, newest first.
Cannara Expands International Supply Agreement with Curaleaf
October 5, 2026
Cannara Expands Financing to an $80 Million Syndicated Credit Facility with BMO and TD Bank, Further Strengthening Its Financial Foundation for Continued Growth
September 10, 2026
Cannara Appoints Nicholas Fozard as Chief Financial Officer
September 1, 2026
Cannara Establishes Automatic Share Purchase Plan
August 13, 2026
Cannara Announces Normal Course Issuer Bid
July 22, 2026
Cannara Reports Record Q3 Revenues and Continued Profitability Accompanied By Expanding National Distribution and Accelerated Capacity Expansion
July 15, 2026
Cannara Announces a Long-Term International Cannabis Supply Agreement with Curaleaf International Limited
July 14, 2026
Cannara to Announce Fiscal Q3 2026 Financial Results on July 15, 2026
July 8, 2026
Cannara Secures Exclusive Canadian Rights to Blue River's Ampersand(TM) Live Rosin Infusion Technology
July 2, 2026
Cannara Completes Acquisition of Medican Organic Inc.
May 6, 2026
Cannara Reports Q2 Fiscal 2026 Results with Continued Profitability, Strong Operating Cash Flow and #1 Retail Market Share in Québec
April 14, 2026
Cannara to Announce Fiscal Q2 2026 Financial Results on April 14, 2026
April 7, 2026
Video - CEO Clips: Cannara Biotech Graduates to Toronto Stock Exchange
March 19, 2026
Cannara Biotech Inc. (LOVE) Opens the Market
March 17, 2026
Cannara Announces Graduation to the Toronto Stock Exchange
February 26, 2026
Cannara to Host Investor Webcast on February 19th, 2026
February 12, 2026
Cannara Announces Strategic C$6.3 Million Non-Brokered Private Placement Priced at C$2.10 per Common Share
February 4, 2026
Cannara Announces Conditional Approval to List on the Toronto Stock Exchange
January 28, 2026
Cannara Reports Q1 Fiscal 2026 Results, Delivers New Record Financial Results, Extends Market Share Gains and Advances Disciplined Expansion Strategy
January 26, 2026
Cannara Achieves OTCQX Qualification and Announces Release of Fiscal Q1 2026 Financial Results on January 26, 2026
January 14, 2026
Cannara Achieves #1 Market Share Position in Québec as of December 2025 and Provides Update on Québec Vape Category Launch
January 2, 2026
Calls in 2026
Decks in 2026
- Q3 2026 Earnings Presentation
Earnings · 23 slides · Jul 15, 2026
- Investor Presentation (July 2026)
Investor deck · 23 slides · July 2026
- Q2 2026 Earnings Presentation
Earnings · 22 slides · Apr 14, 2026
- Investor Presentation (April 2026)
Investor deck · 22 slides · April 2026
- Investor Presentation (March 2026)
Investor deck · 23 slides · March 2026
- Investor Presentation (March 2026)
Investor deck · 23 slides · March 2026
- Q1 FY2026 Earnings Presentation
Earnings · 22 slides · January 2026
- Q1 2026 Earnings Presentation
Earnings · 22 slides · January 2026